COMPARATIVE EFFICACY OF А MEMBER OF THE NEW CLASSOF ORAL BLOOD GLUCOSE-LOWERING AGENT «BATION»(ANTIBODIES TO THE INSULIN RECEPTOR) IN PATIENTS WITH TYPE II DIABETES
- Authors: Petrov VI1, Rogova NV1, Ryazanova AY.1, Sergeeva SA1, Kachanova MV1, Zabolotneva Y.A1, Epshteyn OI1, Petrov VI1, Rogova NV1, Ryazanova AU1, Sergeeva SA1, Katchanova MV1, Zabolotneva UA1, Epshtein OI1
-
Affiliations:
- Issue: Vol 5, No 4 (2008)
- Pages: 11-14
- Section: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/118000
- ID: 118000
Cite item
Full Text
Abstract
dilutions of С12-С30-С200, «Scientific and Industrial Manufacturer «Materia Medica Holding», Ltd, Russia), is a novel drug
developed to treat type II diabetes. A conducted clinical trial showed that the drug was effective and safe when used in patients
with type II diabetes of moderate severity. Taking into account the effectiveness and safety of this drug, Bation can be recommended
as a prescription medication for patients with moderate forms of type II diabetes when disturbance of carbohydrate metabolism
is moderately manifested.
About the authors
V I Petrov
N V Rogova
A Yu Ryazanova
S A Sergeeva
M V Kachanova
Yu A Zabolotneva
O I Epshteyn
V I Petrov
N V Rogova
A U Ryazanova
S A Sergeeva
M V Katchanova
U A Zabolotneva
O I Epshtein
References
- Бородина В. И. Сахарный диабет. Клиника, диагностика, поздние осложнения, лечение (учебно-методическое пособие) - М.: ИД «Медпрактика-М».- 2006. - 60 с.
- Вербовой А. Ф., Косарева О. В. Клиническая фармакология гипогликемизирующих средств: Учебно-справочное пособие. - Самара: СамГМУ, 1999. - 76 с.
- Майоров А. Ю., Науменкова И. В. // РМЖ. - 2001. - Т. 9, № 24.
- Чазова Т. Е. // РМЖ. - 2003. - Т. 11, № 27.
- Эпштейн О. И., Штарк М. Б., Дыгай А. М. и др. Фармакология сверхмалых доз антител к эндогенным регуляторам функций / Монография. - М.: Издательство РАМН. - 2005.
Supplementary files
